Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2Other neoplasm 1

Conditions

Precancerous Conditions 1Keratosis, Actinic 1

Interventions

Sulindac 4Biopsy 4Carboplatin 3Vaginal Smears 2Specimen Handling 2Cyclophosphamide 2Colposcopy 2Aspirin 2tipifarnib 1tanespimycin 1sargramostim 1radium Ra 223 dichloride 1pirfenidone 1fludarabine phosphate 1alethine 1X-Rays 1Taxes 1Sorafenib 1Resistance Training 1Radiotherapy 1Polymerase Chain Reaction 1Photons 1Peripheral Blood Stem Cell Transplantation 1Papanicolaou Test 1Paclitaxel 1Mycophenolic Acid 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Lovastatin 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Deoxyribonuclease (Pyrimidine Dimer) × Other neoplasm × Clear all
NCT00002811 2013-11-06

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

National Cancer Institute (NCI)

Phase 3 Unknown
30 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡